
Business
AIRS Medical gets TA backing for MRI AI expansion
The strategic growth investment will support AIRS Medical’s international expansion and product development across SwiftMR and SwiftSight. Financial terms were not disclosed.
Company

The strategic growth investment will support AIRS Medical’s international expansion and product development across SwiftMR and SwiftSight. Financial terms were not disclosed.

SimonMed selected AIRS Medical’s SwiftMR as its enterprise-wide MRI enhancement platform. The FDA-cleared software will be deployed across SimonMed’s national outpatient imaging network.

SwiftMR can now operate with OEM deep-learning reconstruction pipelines to add scan-time reduction or extend AI image enhancement to more MRI sequences.